Also, non-canonical, weakly activating germline JAK2 variants may predispose progenitor cells to acquire JAK2-V617F and accelerate MPN progression to acute myeloid leukemia (AML) [8, 9]. Here, JAK2 is linked to myeloproliferative neoplasm.